| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,567 |
5,180 |
$142K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,425 |
1,189 |
$26K |
| 99497 |
|
201 |
169 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
629 |
520 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
238 |
213 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
65 |
49 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
52 |
50 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,092 |
966 |
$900.39 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
53 |
13 |
$673.02 |
| 80305 |
|
245 |
217 |
$543.12 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
28 |
27 |
$451.70 |
| 90688 |
|
46 |
40 |
$233.53 |
| 99407 |
|
33 |
25 |
$232.79 |
| G0008 |
Administration of influenza virus vaccine |
93 |
76 |
$213.72 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
24 |
$197.02 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
30 |
12 |
$125.36 |
| 1159F |
|
5,047 |
3,666 |
$110.00 |
| 1160F |
|
5,048 |
3,667 |
$110.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
17 |
12 |
$100.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
33 |
28 |
$68.68 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
38 |
30 |
$58.61 |
| 3008F |
|
2,181 |
1,558 |
$50.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
24 |
$6.23 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,997 |
3,848 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
102 |
89 |
$0.00 |
| 1158F |
|
60 |
54 |
$0.00 |
| 4004F |
|
90 |
84 |
$0.00 |
| 1124F |
|
101 |
87 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
100 |
88 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
250 |
179 |
$0.00 |
| 4040F |
|
47 |
41 |
$0.00 |
| 99072 |
|
37 |
25 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
39 |
36 |
$0.00 |
| 1157F |
|
60 |
54 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
186 |
143 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
114 |
102 |
$0.00 |
| 1036F |
|
51 |
42 |
$0.00 |
| 3017F |
|
140 |
118 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
16 |
15 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
15 |
14 |
$0.00 |